Video & Transcript Research : 'FDA'
Page 16 of 62
AR
Arkansas 2026 1st Special Session
ALC-STATE INSURANCE PROGRAMS OVERSIGHT SUBCOMMITTEE Feb 18th, 2026
ALC-STATE INSURANCE PROGRAMS OVERSIGHT SUBCOMMITTEE
Transcript Highlights:
- Items five, six, nine, and ten, and eleven are all updating due to FDA updates in guidelines.
- Are all updating due to FDA updates in guidelines and dosing recommendations.
Summary:
The State Insurance Programs Oversight Subcommittee met to review and approve several State Board of Finance actions related to employee benefits and pharmacy coverage. Grant Wallace, Director of the Employee Benefits Division and Office of Property Risk, presented a $280,000 Boston Consulting Group contract to help develop a third-party administration RFP, and the committee approved it. The committee then considered pharmacy formulary recommendations for December 2025, January 2026, and February 2026, along with February 2026 medical drug recommendations.
Across the formulary items, Wallace explained that some drugs were being removed from prior authorization requirements, some were being updated to reflect FDA guidance or dosage changes, and others were being left not covered because lower-cost alternatives already exist or clinical evidence was insufficient. Notable changes included removing Skyrizi and Renvoke from the pharmacy formulary in favor of lower-cost biosimilars, adding certain generics, and adding a subcutaneous version of Keytruda for faster administration. The committee approved each set of recommendations by motion and voice vote.
Members also raised broader questions about the impact of new drug-pricing programs such as Trump RX, Cost Plus, and other manufacturer discount efforts, as well as concerns about PBM oversight and whether Navitus is complying with state law. Wallace said the department is still studying those issues and working with Navitus to assess pricing opportunities and compliance. Senator Boyd also asked about whether affiliated pharmacies are being paid more than independent pharmacies, noting he had not received a prior response; Wallace was asked to follow up. The meeting concluded with no further business and adjournment.
FL
Transcript Highlights:
- The bill currently authorizes specific doctors to perform FDA-approved stem cell therapies for certain
- I do think it's important to clarify that stem cells are FDA approved.
- And then they shut down because this is still regulated by the FDA.
- In fact, I’ve got a list of about 20 off-label therapies that have FDA-approved uses for other things
- . ...label therapies that have FDA-approved uses for other things.
Summary:
The committee took up a series of bills, beginning with SB 1422 on unmanned aircraft systems. The bill increases penalties for flying drones over critical infrastructure, prohibits drones equipped with weapons or explosives, creates a first-degree felony for drones carrying a weapon of mass destruction, and includes a law enforcement exception. A lay-filed amendment by Senator Pizzo warning against the use of force to shoot down drones was debated but failed, and the bill was then reported favorably. The committee also reported favorably on SB 846 addressing notary public fraud in immigration-related services, SB 650 on hazardous walking conditions for school transportation, SB 922 on employment agreements including non-compete and garden leave provisions, and SB 1820 on motor vehicle manufacturer and dealer relations, covering performance measures, retaliation, and franchise termination standards.
Several bills focused on education, health care, and disability issues. SB 540, the Evan B. Hartzell Act, would require disability history and awareness instruction across grade levels; it drew emotional testimony from the bill sponsor, family members, and supporters, and was reported favorably. SB 998 would allow advanced practice registered nurses to certify deaths and file death certificates in hospice settings under physician protocol, and SB 1412 would modernize home health agency rules by expanding administrative flexibility and contract service use; both passed. SB 1736 would allow direct support professionals and relatives to administer insulin in group home settings for individuals with developmental disabilities, and it was also reported favorably.
The committee also advanced several regulatory and court-related measures. SB 1650 expands Florida’s vexatious litigant law, including allowing designation based on conduct in a single case and extending the look-back period, while SB 1652 creates a public records exemption for certain stricken non-criminal court filings; both were approved. SB 1076 on roofing contractors was amended to require continuing education for roof-to-wall connections and then passed, and SB 1078 on fire prevention was amended with stakeholder-agreed language before being reported favorably. SB 1080 on local government land regulations, after multiple amendments and significant debate over agricultural enclaves and local control, was also approved.
Other major measures included SB 818 on utility relocation, which creates a relocation fund funded by a portion of communications services tax revenue and was supported by multiple industry and local-government groups after a compromise amendment; SB 868 on social media use by minors, which would require a decryption mechanism for law enforcement access under subpoena and prohibit disappearing messages for minors, remained under discussion as the transcript ended. The committee also heard SB 96, a claims bill for Jacob Rogers against the City of Gainesville, and reported it favorably after testimony that the city would pay the settlement amount.
MN
Minnesota 2025 1st Special Session
House Agriculture Finance and Policy Committee 3/26/25
Agriculture Finance and Policy
Transcript Highlights:
- So on the testing of retail milk, the USDA and the FDA have been doing that, and that's how we've been
- of retail milk, um the uh uh USDA<00:43:47.119>
and <00:43:47.200>the <00:43:47.359>FDA - have<00:43:48.000>
been <00:43:48.160>doing <00:43:48.319>that USDA and the FDA - 00:44:13.040>
that But I did want you to know that there is testing going on at the USDA and FDA - On the other uh piece and FDA level.
Keywords:
beginning farmers, agriculture, loans, economic opportunity, farmers' equity, agriculture appropriations, farm to school, early care, child care food program, school lunch program, local food, Minnesota agriculture, food access, farm-to-institution, limited market access, county fairs, biofuels, E25, ethanol, meat processing
MN
Minnesota 2025-2026 Regular Session
Committee on Commerce and Consumer Protection - 03/11/25
Commerce and Consumer Protection
Transcript Highlights:
- The FDA has consistently affirmed that approved biosimilars meet the same rigorous standards as their
- Alternatives through competition<00:31:22.039>
second <00:31:23.039>the <00:31:23.200>FDA - <00:31:23.720>
has competition second the FDA has competition second the FDA has consistently - biologics<00:31:30.279>
in <00:31:30.519>fact <00:31:30.799>the <00:31:30.919>FDA - <00:31:31.399>
recently biologics in fact the FDA recently biologics in fact the FDA recently
MN
Minnesota 2025 1st Special Session
Committee on Health and Human Services - 04/02/25
Health and Human Services
Transcript Highlights:
- disease communities roughly 10,000 rare disease communities have<00:54:45.440>
an <00:54:45.599>FDA - >
treatment <00:54:47.480>um <00:54:47.799>so <00:54:48.160>the have an FDA - approved treatment um so the have an FDA approved treatment um so the work<00:54:48.480>
of <00 - treatable<00:56:52.119>
by <00:56:52.240>a <00:56:52.359>newly <00:56:52.720>FDA - and highly treatable by a newly FDA and highly treatable by a newly FDA approved<00:56:53.680>
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Revenue Jun 21st, 2026 at 01:00 pm
Joint Committee on Revenue
Transcript Highlights:
- Nicotine pouches are recognized by the FDA as a smoke-free, low-risk alternative to traditional cigarettes
- FDA under President Biden, acknowledged that non-combustible nicotine products are substantially less
- And according to the CDC, nicotine pouches are not an FDA-approved method for quitting smoking.
- especially since at least one of the products in that category has received authorization from the FDA
Summary:
The Joint Committee on Revenue held a long hybrid hearing on a wide range of tax bills, with testimony covering cigarette and tobacco taxes, nicotine pouches, contractor rental equipment exemptions, aircraft sales tax exemptions, rolling stock, advanced sales tax payments, a gun and ammunition excise tax, a digital services tax, and a psilocybin cultivation/tax proposal. Committee chairs outlined the hearing process and noted that 39 House-filed sales and excise tax bills were being heard for required reporting by November 28. No votes were taken during the hearing.
On tobacco-related bills, supporters including Senator Keenan, the American Heart Association, the American Cancer Society, and Tobacco Free Mass backed higher cigarette taxes and closing the synthetic nicotine loophole, arguing the measures would reduce youth initiation, encourage cessation, and offset health care costs. Retailers, wholesalers, and convenience-store groups opposed the increases, warning of smuggling, out-of-state purchasing, and harm to small businesses; premium cigar representatives argued cigars should be treated separately from cigarettes. The committee also heard testimony on H. 3067 and related bills concerning nicotine pouches, with public health advocates supporting taxation and industry witnesses urging a lower, more competitive rate.
Several other bills drew sharply divided testimony. United Rentals supported H. 3065 to simplify contractor rental equipment exemption paperwork, while airport and aviation groups opposed bills to repeal the aircraft sales tax exemption, saying it would hurt airport competitiveness and jobs. The Transportation Association of Massachusetts backed rolling stock tax exemptions, saying the current tax discourages fleet investment and interstate commerce. Restaurant industry representatives supported repealing advanced sales tax payments and changing penalty rules, saying businesses were hit with retroactive penalties after unclear pandemic-era changes. On H. 3082, an excise tax on guns and ammunition, gun violence prevention advocates, Roca, and Giffords supported the bill as a dedicated funding source for prevention and survivor services, while sportsmen’s groups opposed it as unfair to lawful gun owners and harmful to conservation funding.
The committee also heard testimony on H. 3208, a digital advertising services tax, with Representative Paulino supporting it as a way to capture revenue from online advertising and fund public needs, while the Chamber of Progress opposed it as costly and burdensome for small businesses and campaigns. Finally, multiple witnesses testified on H. 4050 regarding psilocybin cultivation and taxation: advocates from Mass Healing, Roca, the Reason Foundation, and individuals describing personal medical benefits urged a regulated, permit-based system, while the hearing ended after all signed-up speakers were heard and the chair adjourned the meeting.
NH
New Hampshire 2025 Regular Session
Senate Health and Human Services (05/21/2025)
Health and Human Services
Transcript Highlights:
- We feel that this could, by allowing substitution of these under FDA guidelines, which is what it does
- 57.120>
under allowing substitution of these uh under allowing substitution of these uh under FDA - 08:58.560>
that's <00:08:58.720>what <00:08:58.880>it <00:08:59.040>does FDA - guidelines which that's what it does FDA guidelines which that's what it does in<00:08:59.680>
line
KY
Kentucky 2025 Regular Session
Artificial Intelligence Task Force 2025 (10-9-25)
Transcript Highlights:
- In fact, the FDA has even begun to approve certain AI applications as, quote, digital therapeutics.
- In fact, the FDA has even begun to approve certain AI applications as, quote, digital therapeutics.
- In fact, the FDA has even begun to approve certain AI applications as, quote, digital therapeutics.
- In fact, the FDA has even begun to approve certain AI applications as, quote, digital therapeutics.
- And so I think there may be some urgency to not wait for the FDA to catch up.
Summary:
The committee met with a quorum, approved the prior meeting minutes, and then heard testimony on the use of artificial intelligence in therapy and mental health settings. Representative Lisa Willner and Brenda Rosen of NASW Kentucky argued for “guard rails” on AI chatbots so they cannot present themselves as licensed therapists or replace school counselors, psychologists, or social workers. They said AI can support licensed professionals, but warned that chatbots cannot reliably recognize nonverbal cues, escalate crises, or provide accountable care, and they cited examples of harmful chatbot interactions, including a suicide case and a chatbot telling a user to “Please die.”
The witnesses also raised concerns about data privacy, commercialization of sensitive mental health conversations, and the use of personal clinical content to train AI models. They said minors should require parental consent and suggested transparency about how a chatbot is trained and who created it. They distinguished between unvetted consumer chatbots and AI tools that have been scientifically validated or approved as digital therapeutics, noting that some evidence-based tools may be useful for specific conditions such as depression, anxiety, or eating disorders.
Committee members asked whether regulation should be handled by the legislature or by professional boards, and whether a multi-state model would be preferable to 50 different state approaches. The witnesses generally favored expert-led standards and said a board or panel of experts could review and approve mental health chatbots, but members cautioned that boards can become too restrictive and that legislation should preserve flexibility and avoid discouraging children from seeking help. The discussion ended with a request for the witnesses to restate their proposed policy ideas, including privacy protections, bans on commercialization, limits on training AI with clinical content, transparency requirements, and informed consent.
MN
Transcript Highlights:
- new bill that's going to authorize pharmacists to independently prescribe, dispense, and administer FDA-approved
- Schedule 3, 4, and 5 FDA-approved Schedule 3, 4, and 5 medications medications medications for<00:02
- <01:01:02.800>
And <01:01:03.040>as FDA-approved obesity medications. - And as FDA-approved obesity medications.
- <01:04:42.480>
treatments evidence-based, FDA-approved treatments evidence-based, FDA-approved
Keywords:
opioid use disorder, OUD, medication-assisted treatment, MAT, pharmacist prescribing, pharmacy practice, controlled substances, Schedule III, Schedule IV, Schedule V, DEA registration, Board of Pharmacy, substance use disorder, addiction treatment, buprenorphine, naltrexone, harm reduction, prescription authority, pharmacist intern, Minnesota pharmacy law
MN
Transcript Highlights:
- Professor, an FDA for AI. Yeah, nice. Yes. Thank you very much.
- Professor, an FDA for AI. Yeah, nice. Yes.
- Professor, an FDA for AI. Yeah, nice. Yes.
- Professor, an FDA for AI. Yeah, nice. Yes. All right, thank you very much.
- Professor, an FDA for AI. Yeah, nice. Yes. Yes. All right, thank you very much.
NH
Transcript Highlights:
- that have not been approved by the FDA. that have not been approved by the FDA.
- The FDA approval process exists for a reason.
- The FDA approval process exists for a reason.
- The FDA approval process exists for a reason.
- The FDA approval does not risks. The FDA approval does not guarantee<01:01:16.960>
safety.
TX
Texas 89th Regular
Press Conference: HB 3717 - Texas Ibogaine Initiative Mar 18th, 2025
Texas House Floor Meeting
Transcript Highlights:
- work with Brian and the Vets program, to make sure that Texas is the one who leads on this and we see FDA
- approval of this drug, at the very least clinical studies, to get it FDA approval of this drug, at the
Summary:
The meeting was a Texas Capitol press event in support of House Bill 3717, which would advance ibogaine research and create a public-private pathway to move the treatment toward FDA approval. Speakers included Brian Hubbard of the American Ibogaine Initiative, Rep. Cody Harris, and VETS co-founders Marcus and Amber Capone. They framed the bill as a chance for Texas to lead on treatment for opioid use disorder, PTSD, traumatic brain injury, and other “diseases of despair,” especially among veterans and their families.
Testimony focused heavily on the veteran suicide crisis and personal stories of loss and recovery. Marcus Capone described his Navy SEAL service and said conventional treatments had not been enough for many veterans, while Amber Capone cited VETS’ support for roughly 1,000 veterans and a Stanford collaboration that she said showed large reductions in PTSD, anxiety, depression, and suicidality after ibogaine treatment. Supporters also argued ibogaine may have broader applications, including for other substance use disorders and some neurological conditions, and emphasized the need for research, supervised clinical use, and insurance coverage.
No formal committee vote or legislative action was taken in the transcript. The event ended with a brief Q&A and a call for Texas legislators to support HB 3717 and help move the bill forward.
AL
Alabama 2025 Regular Session
Alabama Senate Fiscal Responsibility and Economic Development Committee Apr 16th, 2025
Fiscal Responsibility and Economic Development
AZ
Arizona 2026 Regular Session
06/10/2026 - House Republican Caucus Calendar #24
AZ
Arizona 2026 Regular Session
06/10/2026 - House Republican Caucus Calendar #24
Transcript Highlights:
- strike-everything amendment that prohibits access from establishing more restrictive utilization controls for FDA-approved
- strike-everything amendment that prohibits access from establishing more restrictive utilization controls for FDA-approved
Summary:
The meeting covered seven Senate-amended House bills on the caucus agenda. HB 248 was described as changing prior language about private process servers and, in the Senate strike-everything version, prohibiting more restrictive utilization controls for FDA-approved non-opioid pain medications than those applied to opioid or narcotic drugs, with a repeal date of September 1, 2028. HB 2265 would continue limiting certain court fees charged to criminal defendants, though the Senate removed the provision barring courts from creating new fees without express legislative authorization. HB 2404 would require authorized transporters for certain mental health transports; the sponsor explained the Senate changes delay implementation until 2030 and preserve officer involvement when safety concerns exist. HB 2611 would strengthen DCS group foster home safety rules, including drug screening consequences for employees and additional security standards, with the sponsor emphasizing child safety and accountability. HB 2950 would authorize tourism improvement areas and lodging assessments, with the Senate shifting assessment approval to the governing body and removing some new-business assessment requirements. HB 2986 made multiple ADEQ-related changes, including replacing the recycling fund with the solid waste fee fund and expanding its uses. HB 2995 revised child custody and domestic violence standards to make domestic violence a dominant factor in custody decisions, with Senate amendments adjusting findings, evidence standards, burdens of proof, and adding an emergency clause.
Most bills were met with sponsor concurrence and no recorded opposition. HB 2404 drew questions about whether peace officers would still be involved in transports; the sponsor clarified officers would still handle the initial pickup and could be recalled if the person remained high risk or aggressive. HB 2611 was supported as a child-protection measure based partly on recommendations from youth in group homes. HB 2950 was described as a private, opt-in tourism financing tool that would cost taxpayers nothing. HB 2986 was noted as having passed the Senate unanimously.
HB 2995 generated the most discussion. Supporters said it addresses coercive control and financial abuse in domestic violence cases and was developed through a lengthy stakeholder process, including court input, to better protect children and families. One member objected that the bill’s wording could sweep in ordinary marital conduct, such as managing finances, making demeaning remarks, or threatening to call police or file for divorce, and urged an amendment to narrow the language. Supporters responded that the bill is aimed at coercive control in custody disputes, that the emergency clause reflects immediate need, and that fixes could be revisited later. The caucus ended with a reminder about a second caucus after floor for the budget bill.
FL
Florida 2025 Regular Session
March 11, 2025 - 10:30 AM
Transcript Highlights:
- bill will allow public schools to purchase, use, and maintain emergency opioid antagonists that are FDA
- Now, it's also NAL-FEN-Mephine, and as we know, FDA is also looking at all the medications that are in
Summary:
The Human Services Subcommittee considered three bills and reported all of them favorably by unanimous votes. HB 355, by Rep. Jay Alvarez, would allow public K-12 schools and postsecondary institutions to purchase, use, and maintain FDA-approved emergency opioid antagonists rather than being limited to naloxone. The bill was described as giving schools more flexibility and a lower-cost option for overdose response; it received supportive public testimony and passed 18-0.
HB 531, by Rep. Hanchowski, expands background screening requirements for child care facilities and programs to include certain recreational enrichment programs, and creates a statewide public awareness campaign about screening requirements. An amendment narrowed the definition of recreational enrichment programs to in-person dance, gymnastics, and martial arts lessons and conformed a statutory cross-reference; the amendment was adopted without objection. The bill then passed 18-0, with support from Florida Smart Justice Alliance and some discussion about strengthening enforcement against bad actors.
HB 1127, by Rep. Weinberger, addresses child welfare by creating a treatment foster care pilot program for high-acuity children, directing DCF to study residential treatment capacity, and improving data collection on commercially sexually exploited children. The bill also includes recruitment and funding proposals for foster parents and workforce strategies for DCF. Members praised the bill’s focus on difficult cases and system gaps, public testimony was supportive, and the bill passed 18-0. The meeting then adjourned.
VT
Transcript Highlights:
- And they all have to be okayed by FDA or USDA or food and drug.
- Yeah, that's FDA or FIFA or whatnot.
- <01:22:05.679>
Yeah, FDA or USDA or food and drug. Yeah, FDA or USDA or food and drug. - <01:22:08.080>
So, <01:22:09.040>we that's FDA or FIFA or whatnot. - So, we that's FDA or FIFA or whatnot.
Summary:
The House opened with a devotional for Mental Health Awareness Month, focused on the fragility and renewability of mental health and the importance of human connection, kindness, and reaching out to people who are struggling. The chamber then handled several referral items, including first reading and referral of Senate Bill 329, an act relating to criminal procedures involving firearms, to the Judiciary Committee. It also referred Senate Bills 323 and 326 to the Committee on Appropriations because they carry appropriations, and noted that Senate Bill 278, relating to cannabis and state revenue, had been reported favorably with amendment and was referred to Ways and Means under House Rule 35A.
The House took up Joint Senate Resolution 53 on weekend adjournment for May 15, 2026, and adopted it in concurrence by voice vote. The chamber also read House Concurrent Resolution 284 honoring former Senate Majority Leader and Department of State’s Attorneys and Sheriffs’ Executive Director John F. Campbell for his public service, including his work on marriage equality and gun control, and members gave remarks recognizing his leadership, humor, and impact on the institution. Several guests were welcomed and recognized during announcements, including a representative involved in a diaper drive, local officials, and Norma Malone, who was honored for decades of public service in Barry Town and related local boards.
The main floor action was on Proposal 4, a proposed constitutional amendment on equality of rights. The Judiciary Committee recommended concurrence, and the member from Burlington explained the amendment’s purpose and process, emphasizing that it would add an equal protection guarantee to the Vermont Constitution covering race, ethnicity, sex, religion, disability, sexual orientation, gender identity, gender expression, and national origin, while preserving other constitutional protections. The member also reviewed the proposal’s prior passage in both chambers in the previous biennium and its current path toward appearing on the November 2026 ballot if approved again by the House and Senate. The transcript ends while the House is still hearing extended remarks on Proposal 4, with no final vote on the amendment shown in the excerpt.
HI
Transcript Highlights:
- So, we want to make sure that access to all FDA-approved sunscreens is kept available and that state
- funds should be made for all FDA-approved, you know, quote-unquote legal sunscreens for Hawaii should
- So, we want to make sure that access to all FDA-approved sunscreens is kept available and that state
- funds should be made for all FDA-approved, you know, quote-unquote legal sunscreens for Hawaii should
- >> Yeah, and then under FDA approval is... >> So, specifically, you believe these products pose less
Keywords:
invasive species, agriculture, biosecurity, lease provisions, environment, natural resources, flood management, vegetation removal, Kainahola stream, Hawaii legislation, trees, exceptional trees, significant trees, urban forestry, arborist advisory committee, DLNR, Department of Land and Natural Resources, University of Hawaii, county planning, tree preservation
Summary:
The committee heard several measures related to agriculture, invasive species control, trees, reef protection, and land use. SP 2489 would require Department of Agriculture and Biosecurity leases to include access, invasive-species control, and termination provisions; DAB and DLNR supported it, as did several outside groups, while the Hawaii Farm Bureau and Hawaii Cattlemen’s Council raised concerns about notice, cooperation with lessees, and placing penalties on leaseholders for preexisting infestations. The chair noted six testifiers in support, one opposed, and three with comments.
SP 2310 would appropriate funds to remove overgrown vegetation from the Kohola stream. DAB supported the bill but explained that the work already completed by its contractor stopped at a DOT boundary, and that the affected parcel appears to be a DOT highway segment on ceded lands; the committee discussed whether the appropriation should instead go to DOT. SP 2372, on exceptional and significant trees, received support from DNR and Outdoor Circle, with testimony describing trees as critical infrastructure and suggesting technical amendments to committee membership and the process for recommending trees to county councils. SP 2426, which would authorize DNR to contract with private parties to maintain sunscreen dispensers at state beaches and promote mineral-based sunscreen as reef-protective, drew support from DNR and reef advocates, while another witness questioned the science behind claims about mineral versus chemical sunscreens and urged broader environmental solutions.
SP 2334 would impose a land conversion fee on agricultural land converted to other uses, create a fee fund for programs including healthy soils, and require state agricultural lands to use a conservation metric. DAB offered comments, and testimony from climate and farm groups generally supported the conservation goals but questioned references to programs not yet in place and objected to language excluding solar and wind uses, with one witness urging that agri-voltaics remain allowed. SP 2925, concerning coconut trees, would recognize them as food, water, and cultural resources, require signage for landscape palms, set labeling standards, and create a tax credit for naturally managed consumable coconut trees. DAB shifted from opposition to comments, DNR supported, and testimony from cultural and subsistence advocates strongly backed the bill as a response to coconut rhinoceros beetle impacts; committee questions focused on enforcement of signage, inspection resources, and the proposed tax credit.
MO
Missouri 2026 Regular Session
Substance Abuse Prevention and Treatment Task Force Jun 25th, 2026 at 09:00 am
Substance Abuse Prevention and Treatment Task Force
Transcript Highlights:
- Now, there are several FDA-approved medications for opioid use disorder, which function...
- Now, there are several FDA-approved medications for opioid use disorder, which function by alleviating
- So that's FDA, the IRS, the U.S. Attorney's Office.
- But according to a 2025 FDA report, 7-OH produces respiratory depression at a rate three times that of
- The sale of a new drug without FDA approval and the rigorous safety testing required for such approval
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Mental Health, Substance Use and Recovery Jun 21st, 2026 at 01:00 pm
Joint Committee on Mental Health, Substance Use and Recovery
Transcript Highlights:
- Federally, the FDA has assigned its breakthrough therapy designation to multiple psychedelics.
- Some such introductions have recently been made with FDA-approved medications, such as radanolone, which
- approval by some are called psychedelics and not by others; they already have FDA approval.
- approval by some are called psychedelics and not by others, they already have FDA approval.
- Senator Talents, is psilocybin approved by the FDA? No, it is a Schedule I. Thank you.
Summary:
The Joint Committee on Mental Health, Substance Use and Recovery opened its first public hearing of the 2025–26 session with remarks from the Senate and House chairs outlining the committee’s priorities. They noted recent work on addiction and recovery legislation, the ongoing youth behavioral health crisis, and that members might need to leave periodically for floor votes. The chairs explained hearing procedures, including three-minute testimony limits, written testimony deadlines, and reporting deadlines for Senate and House bills. The hearing then focused on several bills related to youth mental health, overdose prevention, and psychedelic treatment research.
A major portion of the hearing centered on bills to improve youth crisis response and overdose prevention. Testimony strongly supported bills to print the 988 Suicide and Crisis Lifeline on student ID cards, with speakers from mental health organizations, crisis centers, and individuals sharing personal stories of depression, suicide attempts, and the importance of making 988 as familiar as 911. Another set of bills would require schools to stock naloxone and provide overdose prevention education. Physicians, harm reduction advocates, students, and grieving family members testified that school-based Narcan access and education could save lives, reduce stigma, and help students recognize overdoses and understand Good Samaritan protections. Senator O’Connor and Tamika Perry also testified for a bill to strengthen substance use prevention education and reduce overdose abandonment, emphasizing the need to teach students about overdose risks and the legal protections for calling 911.
The committee also heard testimony on a bill to authorize a pilot program for psychedelic treatment in licensed facilities. Senator Friedman and several medical and behavioral health professionals argued the proposal was a narrow, research-based approach distinct from the broader ballot question rejected in 2024. They said the bill would allow only a small number of supervised clinics to use psychedelics for conditions such as depression, PTSD, anxiety, and substance use disorders, with data reporting and Department of Public Health oversight. Supporters described it as a cautious way to study promising treatments while avoiding unsupervised or commercialized use.
Finally, the committee heard support for a bill to create a special commission and five-year strategic plan for children’s behavioral health services, with testimony that the current system is fragmented, difficult for families to navigate, and strained by workforce and funding challenges. No votes or final actions were taken during the hearing; the committee primarily received testimony and questions on the bills.